ALLMedicine™ Cluster Headache Center
Research & Reviews 766 results
https://doi.org/10.1007/s11916-022-01063-5 10.1016/S1474-4422(17)30405-2 10.1177/0333102419867280 10.1111/head.12866 10.1038/nrneurol.2016.134 10.1136/practneurol-2018-002124 10.1007/s40263-019-00696-2 10.1046/j.1468-2982.2000.00026.x 10.1177/0333102410363490 10.1136/jnnp-2018-320113 10.1111/ner.12869 10.1007/s11916-004-0030-z 10.1016/j.ctim.2007.05.002 10.1177/0333102412458190 10.3109/02813432.2014.944410 10.1007/s11916-014-0413-8 10.1111/head.13516 10.1111/head.14063 10.1111/j.1526-4610.1990.hed3007411.x 10.1212/01.WNL.0000046589.45855.30 10.1001/jama.2009.1855 10.1111/j.1600-0404.1993.tb04189.x 10.1093/bja/aen103 10.2217/pmt-2017-0049 10.1017/ice.2016.171 10.1111/j.1526-4610.2006.00534.x 10.1177/0333102415583145 10.1080/02791072.2015.1107664 10.1177/0333102418804160 10.1111/head.13295 10.1111/head.13473 10.1093/nar/gkw419 10.1080/1355621021000005937 10.1111/j.1755-5949.2008.00059.x 10.3389/fphar.2018.00177 10.1186/s12982-015-0037-4 10.1016/j.shpsc.2011.07.003 10.1007/s13194-017-0169-1 10.1093/bjps/axw008 10.3389/fncir.2014.00052 10.1177/0333102412452044 10.1007/s13311-020-00962-y 10.1021/acs.jnatprod.9b01061
Current Pain and Headache Reports; Rusanen SS, De S et. al.
Jun 28th, 2022 - The use and efficacy of various substances in the treatment of CH have been studied in several retrospective surveys. The aim of the study is to systematically review published survey studies to evaluate the reported efficacies of both established...
https://clinicaltrials.gov/ct2/show/NCT02655523
Jun 23rd, 2022 - Greater occipital nerve (GON) injection is a commonly performed diagnostic and therapeutic procedure in headache patients. GON blocks have been shown to be effective in the treatment of a variety of headaches including occipital neuralgia, migrain...
https://clinicaltrials.gov/ct2/show/NCT04688775
Jun 21st, 2022 - Eligible participants will be randomly assigned to receive treatment, in a blinded manner, two infusions of either eptinezumab or placebo in a cross-over manner during the Placebo-controlled Period and Active Treatment Period of the study. The tot...
https://clinicaltrials.gov/ct2/show/NCT05064397
Jun 16th, 2022 - The participants who take part in this trial will be asked to stay in the trial for about a year. The participants will be asked to visit the trial site 7 times during the trial. In between trial site visits, they will have scheduled phone calls w...
https://clinicaltrials.gov/ct2/show/NCT04066023
Jun 14th, 2022 - This is a randomized, double-blinded, placebo-controlled study. Approximately 120 subjects who meet the entry criteria will be randomized 1:1:1 to receive one of three blinded treatments [C213 1.9 mg patch and placebo patch; C213 3.8 mg (1.9 mg x ...
Drugs 171 results see all →
Clinicaltrials.gov 99 results
https://clinicaltrials.gov/ct2/show/NCT02655523
Jun 23rd, 2022 - Greater occipital nerve (GON) injection is a commonly performed diagnostic and therapeutic procedure in headache patients. GON blocks have been shown to be effective in the treatment of a variety of headaches including occipital neuralgia, migrain...
https://clinicaltrials.gov/ct2/show/NCT04688775
Jun 21st, 2022 - Eligible participants will be randomly assigned to receive treatment, in a blinded manner, two infusions of either eptinezumab or placebo in a cross-over manner during the Placebo-controlled Period and Active Treatment Period of the study. The tot...
https://clinicaltrials.gov/ct2/show/NCT05064397
Jun 16th, 2022 - The participants who take part in this trial will be asked to stay in the trial for about a year. The participants will be asked to visit the trial site 7 times during the trial. In between trial site visits, they will have scheduled phone calls w...
https://clinicaltrials.gov/ct2/show/NCT04066023
Jun 14th, 2022 - This is a randomized, double-blinded, placebo-controlled study. Approximately 120 subjects who meet the entry criteria will be randomized 1:1:1 to receive one of three blinded treatments [C213 1.9 mg patch and placebo patch; C213 3.8 mg (1.9 mg x ...
https://clinicaltrials.gov/ct2/show/NCT02910323
May 25th, 2022 - The Will Erwin Headache Research Center will assemble a national registry of Cluster Headache patients and will sub-categorize and organize this cohort based on individuating characteristics including but not limited to type and severity of condit...
News 150 results
https://www.medscape.com/viewarticle/968494
Feb 15th, 2022 - Cluster headache attacks induced by either pituitary adenylate cyclase-activating polypeptide-38 (PACAP38) or vasoactive intestinal polypeptide (VIP) do not lead to changes in plasma levels of calcitonin gene-related peptide (CGRP) or markers of m...
https://www.mdedge.com/neurology/article/251757/headache-migraine/pacap38-and-vip-induced-cluster-headache-attacks-do-not
Steve Cimino
Feb 14th, 2022 - Cluster headache attacks induced by either pituitary adenylate cyclase-activating polypeptide-38 (PACAP38) or vasoactive intestinal polypeptide (VIP) do not lead to changes in plasma levels of calcitonin gene-related peptide (CGRP) or markers of m.
https://www.medscape.com/viewarticle/966922
Jan 20th, 2022 - Intranasal ketamine may be a viable treatment option for acute cluster headache attacks, a pilot study has found, though it did not reduce pain intensity as quickly as initially anticipated. "In clinical practice, intranasal ketamine might be a va...
https://www.mdedge.com/neurology/article/250915/headache-migraine/ketamine-nasal-spray-provides-slow-acting-relief-cluster
Steve Cimino
Jan 19th, 2022 - Intranasal ketamine may be a viable treatment option for acute cluster headache attacks, a pilot study has found, though it did not reduce pain intensity as quickly as initially anticipated. “In clinical practice, intranasal ketamine might be a va.
https://www.mdedge.com/migraine-challenge-center/article/250911/migraine/woman-throbbing-unilateral-headache
Jan 19th, 2022 - Migraine is a complex disorder characterized by recurrent episodes of headache, most often unilateral and in some cases associated with photophobia or phonophobia — a constellation known as aura — that usually arises before the head pain but may a.